title: Acute liver failure in under two year-olds--are there markers of metabolic disease on admission?
abstract: BACKGROUND
  The early establishment of an etiology for acute liver failure (ALF) in infants is essential for the start of adequate treatment in the shortest timeframe possible.
  
  
  OBJECTIVE
  To identify markers of inherited metabolic disease on admission in children under two years of age with ALF.
  
  
  METHODS
  A retrospective review of the medical records of all children (< 2 years old) with ALF admitted to the pediatric hepatology or intensive care units of a tertiary center over a twenty-three year period (January 1989 to December 2011) was done. Patients were divided into two groups: with (group A) or without (group B) a metabolic etiology. Clinical and laboratory parameters on admission were compared.
  
  
  RESULTS
  Twenty-three children met inclusion criteria. Twelve had ALF of metabolic origin (group A). The median age in this group was 2.25 (Q1-Q3: 0.63-4.65) months and in group B 8.0 (Q1-Q3: 1.5-15) months. History of failure to thrive and/or vomiting was more frequent in group A (p = 0.022). Age, gender, encephalopathy and left ventricular hypertrophy were similar in both groups (p = 0.147, p = 1.000, p = 0.637, p = 1.000, respectively). Laboratory tests on admission (plasma lactate, ammonia, cholesterol, phosphate, INR, glucose, bilirubin, ALT, base excess and the presence of reducing substances in urine) showed no statistically significant differences between groups.
  
  
  CONCLUSIONS
  This study showed that although infants with inborn errors of metabolism showed a trend towards lower age at presentation, the only marker of inherited metabolic disease found on admission was history of vomiting and/or failure to thrive.
authors.affiliation: Unidade de Hepatologia.
authors.forename: Ana
authors.initials: A
authors.lastname: Brett
authors.forename: Carla
authors.initials: C
authors.lastname: Pinto
authors.forename: Leonor
authors.initials: L
authors.lastname: Carvalho
authors.forename: Paula
authors.initials: P
authors.lastname: Garcia
authors.forename: Luísa
authors.initials: L
authors.lastname: Diogo
authors.forename: Isabel
authors.initials: I
authors.lastname: Gonçalves
mesh_terms: D000367:Age Factors; D015415:Biomarkers / Q000097:blood; D005183:Failure to Thrive / Q000209:etiology; D005260:Female; D006801:Humans; D007223:Infant; D053208:Kaplan-Meier Estimate; D017114:Liver Failure, Acute / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D008297:Male; D008661:Metabolism, Inborn Errors / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D010343:Patient Admission; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D062606:Tertiary Care Centers; D014839:Vomiting / Q000209:etiology
chemical_list: D015415:Biomarkers